Mitotic kinesin inhibitors and methods of use thereof
申请人:Hans Jeremy
公开号:US20060100161A1
公开(公告)日:2006-05-11
This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.
Mitotic Kinesin Inhibitors and Methods of Use Thereof
申请人:Hans Jeremy
公开号:US20080182992A1
公开(公告)日:2008-07-31
This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.
MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF
申请人:Hans Jeremy
公开号:US20110201651A1
公开(公告)日:2011-08-18
This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.
[EN] ESTER DERIVATIVES OF N4-HYDROXYCYTIDINE AND USE THEREOF<br/>[FR] DÉRIVÉS D'ESTER DE N4-HYDROXYCYTIDINE ET LEUR UTILISATION
申请人:SUZHOU SPRING SEA BIO PHARMACEUTICALS CO LTD
公开号:WO2023083295A1
公开(公告)日:2023-05-19
The present disclosure relates to ester derivatives of N4-hydroxycytidine (NHC), to pharmaceutical compositions comprising thereof, to the preparation method thereof, and to the use and method of the ester derivatives of N4-hydroxycytidine to treat viral infections.